Profil
Alan Cherrington is the founder of Abvance Therapeutics, Inc. founded in 2016.
Dr. Cherrington is currently a Professor at Vanderbilt University.
Former positions include Director at Protemix Corp.
Ltd. and President at American Diabetes Association.
Aktive Positionen von Alan Cherrington
| Unternehmen | Position | Beginn |
|---|---|---|
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 25.03.2009 |
Ehemalige bekannte Positionen von Alan Cherrington
| Unternehmen | Position | Ende |
|---|---|---|
Protemix Corp. Ltd.
Protemix Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 13.07.2011 |
Abvance Therapeutics, Inc.
Abvance Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing insulin | Gründer | - |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Protemix Corp. Ltd.
Protemix Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
Abvance Therapeutics, Inc.
Abvance Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing insulin | Health Technology |
















